This email list is not sold or distributed, and serves only as an annual reminder of the availability of research support through the BrightFocus Foundation (www.brightfocus.org). Please follow instructions on the notification emails for removal requests.
BrightFocus has awarded more than $120 million to save sight and mind by
funding innovative research worldwide, as of July 1, 2012.*
Click on the tabs to learn more about funding opportunities or apply for a grant as it pertains to Alzheimer's, macular degeneration, or glaucoma.
Since 1985, BrightFocus Alzheimer's Disease Research (ADR) has awarded more than $78 million to support promising research in fields ranging from molecular biology to epidemiology. ADR is currently supporting 54 outstanding biomedical research projects.
Macular Degeneration Research (MDR) is the newest BrightFocus program. Since 1999, BrightFocus has awarded over $12.5 million to support basic research into the causes and potential treatments of this disease. MDR is currently supporting 31 biomedical research projects.
Since National Glaucoma Research (NGR) began in 1978, BrightFocus has awarded more than $21.1 million to support basic research into the causes and potential treatments of this disease. NGR is currently supporting 31 biomedical research projects.
Macular Degeneration Research($120,000 budgeted over 2 years)
FY13 Letter of Intent due July 10, 2013
FY13 full application (by invitaion only) due November 8, 2013
Please sign up for email notification of new RFP announcements and application deadlines by using the following link to our website: E-mail notification
Stanley Prusiner, M.D. Stanley Prusiner, M.D., a neurobiologist at the University of California at San Francisco, was awarded the 1997 Nobel Prize in Medicine for his groundbreaking discovery and definition of a new class of disease-causing agents called prions. Dr. Prusiner's early research program was supported by BrightFocus. He now serves as an honorary member of the BrightFocus board of directors. Read more…
Apply for Grant Funding
Find out about current funding opportunities and how to apply for grants online. Find out more...
Researchers, find all the necessary reporting forms and follow up information required after receiving a grant. Find out more...
Molecular Neurodegeneration: The Official Journal of BrightFocus
Molecular Neurodegeneration (MN) publishes peer-reviewed, original scientific research on the causes of neurodegenerative diseases, like Alzheimer's or Parkinson's, and on the pre-clinical testing of potential therapies for these devastating diseases. MN now ranks in the top 20 percent of neuroscience journals published worldwide with an impact score of 4.28.